Ayushi Chauhan
@Chauhan_AF
Followers
588
Following
6K
Media
6
Statuses
287
Assist. Prof. Lymphoma @MDAndersonNews via @GACancerCenter | @LombardiCancer | @Uconn
Houston, TX
Joined October 2019
RT @drjgauthier: I was lucky to lead this @CIBMTR analysis just published in @AjHematology 👇.🔑 findings:.💡 CD19 CAR….
0
19
0
RT @geltamo: Secondary central nervous system lymphoma (SCNSL) in mantle cell lymphoma (MCL): Characteristics and risk factors in a Danish….
onlinelibrary.wiley.com
In a nationwide cohort study, 873 patients with mantle cell lymphoma (MCL) were followed for a median of 7 years. During follow-up, 28 patients developed secondary central nervous system (CNS)...
0
11
0
RT @PallawiTorkaMD: 🔥 Lymphoma updates from the summer congresses. In this rapid fire conversation with @chadinabhan, I explore the highes….
0
10
0
RT @shreevikaa2029: 🔍 Catch Voices in Lymphoma: Women Shaping Care.👩💼 Career development and mentorship in medicine .Tuesday, August 12 |….
0
5
0
RT @DrRaulCordoba: 🔈🔉🔊 Apply for @EHA_Hematology “Clinical Research Training in #Hematology” #CRTH . This program provides early-career #re….
0
9
0
RT @TheEBMT_Trainee: Passionate about #Hematology #HCT & #CellularTherapy?.We’re opening new spots on @TheEBMT Trainee Committee!🌱.Apply no….
0
12
0
RT @WomenInLymphoma: Together we lead, we learn, we lift each other up. Thank you to all who joined our WiL gathering at #18ICML — an inspi….
0
16
0
RT @drsairahahmed: RWE: Similar outcomes in older adults w bispecific treatment in LBCL with tolerable toxicity profile presented by @Sweth….
0
6
0
RT @GreenLymphoLab: Lymphoma Microenvironment Archetype Profiles (LymphoMAPs). Just presented by @dgermain21 at #18icml @icmlugano, now ava….
cell.com
Li et al. use single nucleus sequencing of 217 large B cell lymphomas to identify microenvironment archetype profiles (LymphoMAPs), discovering their divergent biology and association with clinical...
0
29
0
Miss you all! Big congratulations to a great group of fellows!.
Congratulations to our graduating class of Med Onc/Heme @GACancerCenter fellows. A great group, here with the fellowship program leadership led by Dr. Locke Bryan. @MCG_AUG @AUG_University
0
0
3
RT @MDAndersonNews: Congratulations to Dr. Christopher Flowers, on receiving @ASCO’s 2025 Jamie Von Roenn Excellence in Teaching and Mentor….
mdanderson.org
Christopher Flowers, M.D., division head of Cancer Medicine and chair of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, will be honored with the Jamie Von Roenn Excellence in...
0
10
0
RT @Eddie_Cliff: Glofit+pola for relapsed Burkitt lymphoma @NEJM . Curious, to say the least!. @RoschewskiMD.
nejm.org
Relapsed Burkitt’s lymphoma is nearly always fatal. Three patients had a complete metabolic response with the combination of the bispecific antibody glofitamab and the antibody–drug conjugate ...
0
18
0
RT @majorajay: 15-yr F/U of my fav study by Ardeshna et al.: W&W v Rx4 low tumor burden FL.- median TTNT: NR in R maint, 14.8 yrs (!!!) in….
0
2
0
RT @BloodJournal: B-cell acute lymphoblastic leukemia with MEF2D::BCL9 rearrangement mimicking a Burkitt lymphoma.#….
0
12
0
RT @Lymphoma_Doc: In patients with Hodgkin lymphoma, when should you avoid using Bleomycin and how should you manage pulmonary toxicity? @A….
onlinelibrary.wiley.com
Recommendations from the British Society of Haematology regarding bleomycin pulmonary toxicity (BPT) in classical Hodgkin lymphoma (CHL) centre around (1) appropriate patient selection, (2) routine...
0
16
0
RT @majorajay: PhasED-seq & relapse in cHL #ASH24 @AshAlizadeh:.Early-stage:.- MRD+ at C3D1➡️inferior PFS (despite iPET2 CMRs).- no pts who….
0
2
0
RT @ShannonWestin: Another election is ongoing & we need #healthcare advocacy more than ever- @ASCO members - elect @Lymphoma_Doc to Board….
0
3
0
RT @majorajay: Speaking of. 46 pts with Bing-Neel in UK series #ASH24:.- 1-yr PFS after 1L HD-MTX 81%.- 1-yr PFS after 1L BTKi (mostly zan….
0
5
0
RT @Myeloma_Doc: MD Anderson Cancer Center’s #Lymphoma-#Myeloma Fellowship Program. Contact Program Coordinator: Lisa Foucheaux-Heider (LMF….
0
6
0
RT @tobyeyre82: Hugely important trial results in @JCO_ASCO . Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Tria….
ascopubs.org
PURPOSEThe role of consolidation radiotherapy in patients with primary mediastinal B-cell lymphoma (PMBCL) is controversial.METHODSThe IELSG37 trial, a randomized noninferiority study, aimed to...
0
44
0